Free shipping over €250 · Tracked, discreet delivery in Europe

Short bioregulator peptide

Cartalax

Research compoundNot yet reviewedPeptideIn the catalog

In short: A tripeptide associated with cartilage in Russian bioregulator research. Published evidence is limited.

Regulatory status

  1. Cosmetic ingredient
  2. Research compound
  3. In clinical trials
  4. Approved medicine

Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Common questions

Is Cartalax an approved medicine?

Research compound. Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.

How much human research is there on Cartalax?

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Does UU supply Cartalax?

Yes, as premium-grade research material for laboratory use. Every batch is tested by an independent lab and the certificate of analysis is published.

More in Muscle, bone & joint

Back to the library
  • Cosmeticuu

    GHK-Cu

    Copper tripeptide

    Mixed evidence
  • Researchuu

    SLU-PP-332

    ERR agonist

    Preclinical
  • Researchuu

    IGF-1 LR3

    IGF-1 analogue

    Preclinical
  • Researchuu

    BPC-157

    Gastric pentadecapeptide

    Preclinical
  • Researchuu

    TB-500

    Thymosin beta-4 related peptide

    Mixed evidence
  • Approveduu

    SS-31

    Mitochondria-targeted tetrapeptide

    Human trials

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.